Literature DB >> 29859868

Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events.

Neeraj Singh1, Vivek Lawana1, Jie Luo1, Phang Phong2, Ahmed Abdalla1, Bharathi Palanisamy1, Dharmin Rokad1, Souvarish Sarkar1, Huajun Jin1, Vellareddy Anantharam1, Anumantha G Kanthasamy1, Arthi Kanthasamy3.   

Abstract

The organophosphate (OP) pesticide chlorpyrifos (CPF), used in agricultural settings, induces developmental and neurological impairments. Recent studies using in vitro cell culture models have reported CPF exposure to have a positive association with mitochondria-mediated oxidative stress response and dopaminergic cell death; however, the mechanism by which mitochondrial reactive oxygen species (ROS) contribute to dopaminergic cell death remains unclear. Therefore, we hypothesized that STAT1, a transcription factor, causes apoptotic dopaminergic cell death via mitochondria-mediated oxidative stress mechanisms. Here we show that exposure of dopaminergic neuronal cells such as N27 cells (immortalized murine mesencephalic dopaminergic cells) to CPF resulted in a dose-dependent increase in apoptotic cell death as measured by MTS assay and DNA fragmentation. Similar effects were observed in CPF-treated human dopaminergic neuronal cells (LUHMES cells), with an associated increase in mitochondrial dysfunction. Moreover, CPF (10 μM) induced time-dependent increase in STAT1 activation coincided with the collapse of mitochondrial transmembrane potential, increase in ROS generation, proteolytic cleavage of protein kinase C delta (PKCδ), inhibition of the mitochondrial basal oxygen consumption rate (OCR), with a concomitant reduction in ATP-linked OCR and reserve capacity, increase in Bax/Bcl-2 ratio and enhancement of autophagy. Additionally, by chromatin immunoprecipitation (ChIP), we demonstrated that STAT1 bound to a putative regulatory sequence in the NOX1 and Bax promoter regions in response to CPF in N27 cells. Interestingly, overexpression of non-phosphorylatable STAT1 mutants (STAT1Y701F and STAT1S727A) but not STAT1 WT construct attenuated the cleavage of PKCδ and ultimately cell death in CPF-treated cells. Furthermore, small interfering RNA knockdown demonstrated STAT1 to be a critical regulator of autophagy and mitochondria-mediated proapoptotic cell signaling events after CPF treatment in N27 cells. Finally, oral administration of CPF (5 mg/kg) in postnatal rats (PNDs 27-61) induced motor deficits, and nigrostriatal dopaminergic neurodegeneration with a concomitant induction of STAT1-dependent proapoptotic cell signaling events. Conversely, co-treatment with mitoapocynin (a mitochondrially-targeted antioxidant) and CPF rescued motor deficits, and restored dopaminergic neuronal survival via abrogation of STAT1-dependent proapoptotic cell signaling events. Taken together, our study identifies a novel mechanism by which STAT1 regulates mitochondria-mediated oxidative stress response, PKCδ activation and autophagy. In this context, the phosphorylation of Tyrosine 701 and Serine 727 in STAT1 was found to be essential for PKCδ cleavage. By attenuating mitochondrial-derived ROS, mitoapocynin may have therapeutic applications for reversing CPF-induced dopaminergic neurotoxicity and associated neurobehavioral deficits as well as neurodegenerative diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Chlorpyrifos; Mito-apocynin; Mitochondrial bioenergetics; Neurotoxicity; Oxidative stress; STAT1

Mesh:

Substances:

Year:  2018        PMID: 29859868      PMCID: PMC6108448          DOI: 10.1016/j.nbd.2018.05.019

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  157 in total

1.  Protocol for the MPTP mouse model of Parkinson's disease.

Authors:  Vernice Jackson-Lewis; Serge Przedborski
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

2.  Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.

Authors:  Xiao-Min Zhang; Ming Yin; Min-Hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-07       Impact factor: 6.150

3.  PINK1/Parkin-mediated mitophagy alleviates chlorpyrifos-induced apoptosis in SH-SY5Y cells.

Authors:  Hongmei Dai; Yuanying Deng; Jie Zhang; Hailong Han; Mingyi Zhao; Ying Li; Chen Zhang; Jing Tian; Guoying Bing; Lingling Zhao
Journal:  Toxicology       Date:  2015-06-09       Impact factor: 4.221

4.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

5.  LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells.

Authors:  Peidu Jiang; Noboru Mizushima
Journal:  Methods       Date:  2014-12-05       Impact factor: 3.608

Review 6.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

Review 7.  Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment.

Authors:  Meghan B Azad; Yongqiang Chen; Spencer B Gibson
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

8.  Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson's disease.

Authors:  A G Kanthasamy; M Kitazawa; S Kaul; Y Yang; D K Lahiri; V Anantharam; A Kanthasamy
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

9.  Signal transducer and activator of transcription-1 localizes to the mitochondria and modulates mitophagy.

Authors:  Lauren T Bourke; Richard A Knight; David S Latchman; Anastasis Stephanou; James McCormick
Journal:  JAKSTAT       Date:  2013-07-15

10.  Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease.

Authors:  Souvarish Sarkar; Emir Malovic; Dilshan S Harishchandra; Shivani Ghaisas; Nikhil Panicker; Adhithiya Charli; Bharathi N Palanisamy; Dharmin Rokad; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  NPJ Parkinsons Dis       Date:  2017-10-17
View more
  22 in total

1.  Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson's disease.

Authors:  Dilshan S Harischandra; Dharmin Rokad; Shivani Ghaisas; Saurabh Verma; Alan Robertson; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-08-20       Impact factor: 5.187

Review 2.  Neurotoxicity of pesticides.

Authors:  Jason R Richardson; Vanessa Fitsanakis; Remco H S Westerink; Anumantha G Kanthasamy
Journal:  Acta Neuropathol       Date:  2019-06-13       Impact factor: 17.088

3.  Mechanistic Interplay Between Autophagy and Apoptotic Signaling in Endosulfan-Induced Dopaminergic Neurotoxicity: Relevance to the Adverse Outcome Pathway in Pesticide Neurotoxicity.

Authors:  Chunjuan Song; Adhithiya Charli; Jie Luo; Zainab Riaz; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 4.  Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson's Disease.

Authors:  Jie Luo; Piyush Padhi; Huajun Jin; Vellareddy Anantharam; Gary Zenitsky; Qian Wang; Auriel A Willette; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Neuroimmune Pharmacol       Date:  2019-03-16       Impact factor: 4.147

Review 5.  Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus.

Authors:  Xiangyu Teng; Josephine Brown; Laurence Morel
Journal:  Antioxid Redox Signal       Date:  2022-01-04       Impact factor: 8.401

6.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

7.  Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.

Authors:  Vivek Lawana; Se Young Um; Rachel M Foguth; Jason R Cannon
Journal:  Neurotoxicology       Date:  2020-10-13       Impact factor: 4.294

8.  Time and space-resolved quantification of plasma membrane sialylation for measurements of cell function and neurotoxicity.

Authors:  Petra Kranaster; Christiaan Karreman; Jeremias E G A Dold; Alice Krebs; Melina Funke; Anna-Katharina Holzer; Stefanie Klima; Johanna Nyffeler; Stefan Helfrich; Valentin Wittmann; Marcel Leist
Journal:  Arch Toxicol       Date:  2019-12-11       Impact factor: 5.153

9.  Pinocembrin pretreatment counteracts the chlorpyrifos-induced HO-1 downregulation, mitochondrial dysfunction, and inflammation in the SH-SY5Y cells.

Authors:  Flávia Bittencourt Brasil; Fhelipe Jolner Souza de Almeida; Matheus Dargesso Luckachaki; Evandro Luiz Dall'Oglio; Marcos Roberto de Oliveira
Journal:  Metab Brain Dis       Date:  2021-08-02       Impact factor: 3.584

10.  PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway.

Authors:  Manikandan Samidurai; Bharathi N Palanisamy; Alejandra Bargues-Carot; Monica Hepker; Naveen Kondru; Sireesha Manne; Gary Zenitsky; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Front Aging Neurosci       Date:  2021-07-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.